Stephens Inc’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $814K | Sell |
12,971
-5,160
| -28% | -$413K | 0.01% | 699 |
|
|
2025
Q4 | $1.73M | Sell |
18,131
-2,749
| -13% | -$270K | 0.02% | 509 |
|
|
2025
Q3 | $2.04M | Buy |
20,880
+10,034
| +93% | +$1.04M | 0.03% | 483 |
|
|
2025
Q2 | $1.16M | Buy |
10,846
+1,046
| +11% | +$106K | 0.02% | 589 |
|
|
2025
Q1 | $989K | Sell |
9,800
-746
| -7% | -$75.1K | 0.01% | 615 |
|
|
2024
Q4 | $942K | Buy |
10,546
+148
| +1% | +$13K | 0.01% | 628 |
|
|
2024
Q3 | $871K | Sell |
10,398
-15,654
| -60% | -$1.23M | 0.01% | 642 |
|
|
2024
Q2 | $2.01M | Buy |
26,052
+16,404
| +170% | +$1.2M | 0.03% | 431 |
|
|
2024
Q1 | $661K | Sell |
9,648
-10
| -0.1% | -$643 | 0.01% | 710 |
|
|
2023
Q4 | $558K | Sell |
9,658
-31,481
| -77% | -$1.68M | 0.01% | 705 |
|
|
2023
Q3 | $2.17M | Buy |
41,139
+2,012
| +5% | +$106K | 0.04% | 350 |
|
|
2023
Q2 | $2.12M | Sell |
39,127
-27,979
| -42% | -$1.46M | 0.04% | 368 |
|
|
2023
Q1 | $3.36M | Buy |
67,106
+18,881
| +39% | +$890K | 0.06% | 287 |
|
|
2022
Q4 | $2.23M | Buy |
48,225
+37,711
| +359% | +$1.63M | 0.05% | 344 |
|
|
2022
Q3 | $407K | Sell |
10,514
-477
| -4% | -$19.1K | 0.01% | 777 |
|
|
2022
Q2 | $410K | Sell |
10,991
-3,555
| -24% | -$145K | 0.01% | 799 |
|
|
2022
Q1 | $644K | Sell |
14,546
-4,857
| -25% | -$210K | 0.01% | 723 |
|
|
2021
Q4 | $824K | Buy |
19,403
+4,540
| +31% | +$191K | 0.01% | 690 |
|
|
2021
Q3 | $645K | Sell |
14,863
-1,570
| -10% | -$69.5K | 0.01% | 774 |
|
|
2021
Q2 | $703K | Sell |
16,433
-871
| -5% | -$36.6K | 0.01% | 761 |
|
|
2021
Q1 | $669K | Sell |
17,304
-749
| -4% | -$28.3K | 0.01% | 749 |
|
|
2020
Q4 | $649K | Buy |
18,053
+5
| +0% | +$180 | 0.01% | 710 |
|
|
2020
Q3 | $690K | Buy |
18,048
+132
| +0.7% | +$5.09K | 0.01% | 648 |
|
|
2020
Q2 | $629K | Buy |
17,916
+3,777
| +27% | +$136K | 0.01% | 644 |
|
|
2020
Q1 | $461K | Sell |
14,139
-96
| -0.7% | -$3.75K | 0.01% | 668 |
|
|
2019
Q4 | $644K | Sell |
14,235
-50
| -0.4% | -$2.09K | 0.01% | 663 |
|
|
2019
Q3 | $581K | Buy |
14,285
+1,926
| +16% | +$81.6K | 0.01% | 709 |
|
|
2019
Q2 | $531K | Sell |
12,359
-1,263
| -9% | -$48.6K | 0.01% | 744 |
|
|
2019
Q1 | $523K | Sell |
13,622
-8,429
| -38% | -$322K | 0.01% | 749 |
|
|
2018
Q4 | $779K | Sell |
22,051
-25,003
| -53% | -$907K | 0.02% | 577 |
|
|
2018
Q3 | $1.81M | Buy |
+47,054
| New | +$1.64M | 0.05% | 420 |
|
|
2017
Q2 | – | Sell |
-53,795
| Closed | -$1.34M | – | 875 |
|
|
2017
Q1 | $1.34M | Buy |
+53,795
| New | +$1.31M | 0.05% | 360 |
|
|
2016
Q2 | – | Sell |
-10,683
| Closed | -$201K | – | 770 |
|
|
2016
Q1 | $201K | Sell |
10,683
-2,230
| -17% | -$39.2K | 0.01% | 654 |
|
|
2015
Q4 | $238K | Buy |
12,913
+308
| +2% | +$5.52K | 0.01% | 604 |
|
|
2015
Q3 | $207K | Buy |
12,605
+995
| +9% | +$17K | 0.01% | 639 |
|
|
2015
Q2 | $205K | Buy |
+11,610
| New | +$207K | 0.01% | 703 |
|
Other funds holding BSX
VCM
VPM
Stephens Inc's BSX Position: Q1 2026 in Review
Stephens Inc reduced its Boston Scientific (BSX) stake by 28% in Q1 2026, selling an estimated $413K and leaving 12,971 shares worth $814K. The position accounts for 0.01% of the portfolio, ranked #699.
Stephens Inc first reported a position in BSX in Q2 2015 and has held it in 36 quarters since. The position peaked at $3.36M in Q1 2023. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Stephens Inc held 12,971 shares of Boston Scientific worth $814K as of Q1 2026.
- Stephens Inc sold 5,160 Boston Scientific shares in Q1 2026, an estimated $413K.
- Boston Scientific made up 0.01% of Stephens Inc's portfolio in Q1 2026, its #699 holding.
- Stephens Inc first reported a position in Boston Scientific in Q2 2015 and has held it in 36 quarters since.
- Stephens Inc's Boston Scientific position peaked at $3.36M in Q1 2023.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Stephens Inc's 13F filing for Q1 2026, filed 28 Apr 2026.